FDA APPROVES UPLIZNA® FOR ADULTS WITH GENERALIZED MYASTHENIA GRAVIS

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/20/2026

1. INTC
2. DSX
3. GNK
4. DAL
5. AWK
6. SPCX
7. III
8. TTEC
9. ERLFF
10. META

Go back to FDA APPROVES UPLIZNA® FOR ADULTS WITH GENERALIZED MYASTHENIA GRAVIS
Amgen Inc (NASDAQ: AMGN) Delayed: 337.60 -4.06 (1.19%)
Previous Close $341.66    52 Week High $176.85 
Open $344.38    52 Week Low $133.64 
Day High $345.00    P/E 50.84 
Day Low $334.05    EPS $6.64 
Volume 8,250,202